About Aspy Biotech Private Limited
Data last updated:
Aspy Biotech Private Limited is a private limited company based in Delhi, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC219219. Its GSTIN is 09AAKCA5065C1ZR (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ajay Kumar Agarwal and Alok Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 142 Third Floor Chander Vihar Mandawali Fazalpur Near Primary School, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.04 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹19,931 (net margin 0.2%) and EBITDA of ₹31,982 (EBITDA margin 0.3%). Revenue has declined at a compounded annual rate (CAGR) of 108% over three years and 35% over five years.
Court records list 10 cases involving the company, including 5 filed by the company and 5 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aspy-biotech-pvt-ltd.business.site.
- EmailLocked
- TelephoneLocked
- Social MediaLocked
- Registered Address142 Third Floor Chander Vihar Mandawali Fazalpur Near Primary School, Delhi, India – 110092
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aspy Biotech Private Limited
The main business activity of Aspy Biotech is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aspy Biotech Private Limited FY 2025 filings available
Aspy Biotech Private Limited reported revenue of ₹1.04 Cr (up 163% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aspy Biotech Private Limited
Revenue rose 163% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 35%. EBITDA fell 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aspy Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹31,982 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19,931 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aspy Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aspy Biotech are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aspy Biotech Private Limited
Aspy Biotech Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Coulgen Biotech Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 133.0% | •••• | New Delhi, Delhi, India |
| Dozo Pharma Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 86.0% | •••• | Mohali, Punjab, India |
| Everon Life Sciences Private Limited | ₹1.06 Cr (FY 2017) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Innovation Biologicals Private Limited | ₹1.06 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Pune, Maharashtra, India |
| Transgene Biotek Limited. Listed | ₹1.04 Cr (FY 2025) | •••• | •••• | 150.0% | •••• | Ida Bollaram, Telangana, India |
| Aspy Biotech Private Limited this company | ₹1.04 Cr (FY 2025) | •••• | •••• | 163.0% | •••• | Delhi, India |
| Microvioma Private Limited | ₹1.03 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Bengaluru, Karnataka, India |
| Zelence Industries Private Limited | ₹1.03 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Kharagpur, West Bengal, India |
| Pusilin Biotechnology Private Limited | ₹1.03 Cr (FY 2024) | •••• | •••• | -83.0% | •••• | Kanpur, Uttar Pradesh, India |
| Amines Biotech Private Limited | ₹1.03 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Vadodara, Gujarat, India |
| Biologia Research India Private Limited | ₹1.02 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Karnal, Haryana, India |
Peers are the five companies nearest above and the five nearest below Aspy Biotech by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aspy Biotech Private Limited
Aspy Biotech Private Limited is audited by ALOK HIRA & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ALOK HIRA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aspy Biotech Private Limited
Aspy Biotech has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Agarwal | Director | 16 May 2011 | 15 Years 5 Months | Current |
| Alok Kumar | Director | 08 Nov 2025 | 0 Years 11 Months | Current |
Ownership and Shareholding of Aspy Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aspy Biotech Private Limited
Aspy Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Aspy Biotech Private Limited
Aspy Biotech Private Limited has 10 court cases on record: 5 filed by Aspy Biotech, 5 filed against it. 1 case is pending and 9 are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 5 | 1 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by HDFC Bank Limited | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by R.R.Enterprises Pvt Ltd | Disposed |
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by Hezal Drugs Services | Pending |
| District court, New Delhi, Delhi | Court case (TRAFFIC CHALLAN) | Filed against the company by State | Disposed |
| District court, Shahdara, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Aspy Biotech Private Limited
Employment history and EPFO contributions of people linked to Aspy Biotech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aspy Biotech Private Limited
Aspy Biotech Private Limited has 6 board changes on record since 2011: 3 appointments and 3 cessations. The latest: Alok Kumar was appointed as Director on 08 Nov 2025.
Credit Ratings, Litigation & Regulatory Alerts for Aspy Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aspy Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aspy Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aspy Biotech Private Limited
Aspy Biotech has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCA5065C1ZR | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aspy Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aspy Biotech Private Limited
Aspy Biotech is an active private limited company based in Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 May 2011 (15+ years old) and is registered under CIN U24232DL2011PTC219219.
Aspy Biotech reported revenue of ₹1.04 Cr for FY 2025 (up 163% YoY).
Aspy Biotech has 2 current directors:
- Ajay Kumar Agarwal - Director
- Alok Kumar - Director
Aspy Biotech reported a net profit of ₹19,931 (net margin 0.2%) and EBITDA of ₹31,982 (EBITDA margin 0.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aspy Biotech is 108% over three years and -35% over five years. In the latest year (FY 2025) revenue rose 163%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aspy Biotech is 09AAKCA5065C1ZR, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Aspy Biotech is U24232DL2011PTC219219. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspy Biotech has 10 court cases on record: 5 filed by the company and 5 filed against it. 1 is pending.
Aspy Biotech was incorporated on 16 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aspy Biotech by revenue are Coulgen Biotech Private Limited, Dozo Pharma Private Limited, Everon Life Sciences Private Limited, Innovation Biologicals Private Limited, Transgene Biotek Limited. and 5 more, all in the Biotechnology industry (Biotechnology).
Alok Kumar was appointed as Director on 08 Nov 2025. Hirdesh Gupta ceased to be Additional Director on 30 Sep 2019. Suchit Baijal ceased to be Additional Director on 30 Sep 2019. Aspy Biotech has 6 board changes on record in total.